BRPI0822095A2 - Método para reduzir o sangramento e/ou hematoma em um paciente - Google Patents
Método para reduzir o sangramento e/ou hematoma em um pacienteInfo
- Publication number
- BRPI0822095A2 BRPI0822095A2 BRPI0822095-6A2A BRPI0822095A BRPI0822095A2 BR PI0822095 A2 BRPI0822095 A2 BR PI0822095A2 BR PI0822095 A BRPI0822095 A BR PI0822095A BR PI0822095 A2 BRPI0822095 A2 BR PI0822095A2
- Authority
- BR
- Brazil
- Prior art keywords
- hematoma
- patient
- reducing bleeding
- bleeding
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1591207P | 2007-12-21 | 2007-12-21 | |
PCT/US2008/013797 WO2009082452A1 (en) | 2007-12-21 | 2008-12-17 | Pre-surgical treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0822095A2 true BRPI0822095A2 (pt) | 2014-10-07 |
Family
ID=40801507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0822095-6A2A BRPI0822095A2 (pt) | 2007-12-21 | 2008-12-17 | Método para reduzir o sangramento e/ou hematoma em um paciente |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110224215A1 (pt) |
EP (1) | EP2230910A4 (pt) |
JP (1) | JP5580210B2 (pt) |
KR (1) | KR20100099191A (pt) |
CN (1) | CN101902913B (pt) |
AU (1) | AU2008341112B2 (pt) |
BR (1) | BRPI0822095A2 (pt) |
CA (1) | CA2709199A1 (pt) |
NZ (1) | NZ586302A (pt) |
WO (1) | WO2009082452A1 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US20090061020A1 (en) * | 2007-08-31 | 2009-03-05 | Theobald Klaus P | Brimonidine Compositions for Treating Erythema |
SI2818184T1 (sl) | 2007-11-16 | 2019-03-29 | Aclaris Therapeutics, Inc. | Sestava in postopki za zdravljenje purpure |
AU2010252935C1 (en) * | 2009-05-29 | 2015-05-28 | Galderma Research & Development | Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection |
CA2792646C (en) * | 2010-03-26 | 2018-11-20 | Galderma Research & Development | Improved uses and compositions for safe and effective treatment of erythema |
KR20130010122A (ko) * | 2010-03-26 | 2013-01-25 | 갈데르마 리써어치 앤드 디벨로프먼트 | 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물 |
RU2013123043A (ru) * | 2010-10-21 | 2014-12-10 | Галдерма С.А. | Гелевая композиция для местного применения |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
FR2966366B1 (fr) * | 2010-10-21 | 2012-11-09 | Galderma Sa | Composition de gel de brimonidine |
US20130261126A1 (en) * | 2010-10-21 | 2013-10-03 | Galderma S.A. | Brimonidiine gel compositions and methods of use |
FR2966365B1 (fr) * | 2010-10-21 | 2012-11-09 | Galderma Sa | Composition de gel topique |
FR2977493B1 (fr) * | 2011-07-05 | 2014-02-14 | Galderma Res & Dev | Nouvelle composition anesthesique stable pour la reduction des reactions cutanees |
EP2768502A2 (en) | 2011-10-19 | 2014-08-27 | Galderma S.A. | Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
JP6339364B2 (ja) * | 2013-12-27 | 2018-06-06 | カズマパートナーズ株式会社 | 無定形ブリモニジン酒石酸塩及びその製造方法 |
US20200338111A1 (en) * | 2017-10-23 | 2020-10-29 | Microcures, Inc. | Method for enhancing recovery of cosmetic laser-treated skin |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL92351A (en) | 1988-11-29 | 1994-02-27 | Allergan Inc Irvine | Optimal aqueous solutions containing stabilized chlorine acid and inorganic salt |
US5736165A (en) | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
CA2154979A1 (en) * | 1995-07-28 | 1997-01-29 | Kenneth T. Armstrong | Topical phenylephrine preparation |
US7973068B2 (en) * | 1998-10-20 | 2011-07-05 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
US6294553B1 (en) * | 2000-02-15 | 2001-09-25 | Allergan Sales, Inc. | Method for treating ocular pain |
US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
SI2818184T1 (sl) * | 2007-11-16 | 2019-03-29 | Aclaris Therapeutics, Inc. | Sestava in postopki za zdravljenje purpure |
-
2008
- 2008-12-17 CA CA2709199A patent/CA2709199A1/en not_active Abandoned
- 2008-12-17 KR KR1020107013558A patent/KR20100099191A/ko not_active Application Discontinuation
- 2008-12-17 EP EP08863746A patent/EP2230910A4/en not_active Ceased
- 2008-12-17 JP JP2010539469A patent/JP5580210B2/ja not_active Expired - Fee Related
- 2008-12-17 US US12/809,354 patent/US20110224215A1/en not_active Abandoned
- 2008-12-17 CN CN200880122193.0A patent/CN101902913B/zh not_active Expired - Fee Related
- 2008-12-17 NZ NZ586302A patent/NZ586302A/xx not_active IP Right Cessation
- 2008-12-17 BR BRPI0822095-6A2A patent/BRPI0822095A2/pt not_active IP Right Cessation
- 2008-12-17 WO PCT/US2008/013797 patent/WO2009082452A1/en active Application Filing
- 2008-12-17 AU AU2008341112A patent/AU2008341112B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
KR20100099191A (ko) | 2010-09-10 |
EP2230910A1 (en) | 2010-09-29 |
CN101902913A (zh) | 2010-12-01 |
JP2011507845A (ja) | 2011-03-10 |
EP2230910A4 (en) | 2011-04-13 |
AU2008341112A1 (en) | 2009-07-02 |
JP5580210B2 (ja) | 2014-08-27 |
WO2009082452A1 (en) | 2009-07-02 |
US20110224215A1 (en) | 2011-09-15 |
NZ586302A (en) | 2013-03-28 |
AU2008341112B2 (en) | 2014-02-06 |
CN101902913B (zh) | 2014-06-18 |
CA2709199A1 (en) | 2009-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0822095A2 (pt) | Método para reduzir o sangramento e/ou hematoma em um paciente | |
BRPI0819075A2 (pt) | Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico | |
BRPI0917711A2 (pt) | método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal | |
FI20085839A0 (fi) | Menetelmiä ja välineitä pehmytkudosteknologiaan | |
BRPI0807918A2 (pt) | composições e método para preservação de tecido | |
BRPI0921579A2 (pt) | método para ligar dinamicamente programa em plataforma embutida e plataforma embutida | |
BRPI0807525A2 (pt) | Dispositivo endo-cirúrgico e método | |
BRPI0907162A2 (pt) | Composto, composição farmacêutica e métodos para ativar procaspase executora 3, 6 e/ou 7 e para tratar um estado de doença em um mamífero | |
BRPI0820212A2 (pt) | Dispositivo para tratamento de fraturas, método para tratamento de fraturas, e, kit para tratamento de fraturas | |
BRPI0811996A2 (pt) | Composição amaciante para tecido, e, método para amaciar um tecido | |
BRPI0914035A2 (pt) | ventilador e método para ventilar um paciente usando um ventilador | |
BRPI0910851A2 (pt) | métodos e sistemas para protocolos de harq | |
BRPI0921317A2 (pt) | composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero | |
BRPI0810806A2 (pt) | Método para tratar uma lesão cutânea em um indivíduo | |
BRPI0905851A2 (pt) | Métodos, sistemas, e dispositivos para realizar procedimentos eletrocirúrgicos | |
BRPI0919804A2 (pt) | Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo | |
BRPI0917722A2 (pt) | organismo transgênico e método para manipular o teor de malonatos em um organismo transgênico | |
BRPI0921959A2 (pt) | métodos e composições para remoção de tatuagem | |
BRPI0910763A2 (pt) | métodos e dispositivos para dissecção de tecidos | |
BRPI0821220A2 (pt) | Composiçoes e métodos para reduzir ou prevenir perda de água da pele | |
BRPI0909885A2 (pt) | composição decorativa e método para sua utilização | |
BRPI0920419A2 (pt) | pinça para o osso e a pele. | |
BRPI0907227A2 (pt) | Método e dispositivo para assinatura | |
BRPI0915698A2 (pt) | método para medir o conteúdo de água em um composto e dispositivo de medição de conteúdo de água | |
BRPI0823114A2 (pt) | Dispositivo para cirurgias em prolapsos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |